Literature DB >> 17012430

Combined femoral and Chiari osteotomies for reconstruction of the painful subluxation or dislocation of the hip in cerebral palsy. A long-term outcome study.

U K Debnath1, A R Guha, S Karlakki, J Varghese, G A Evans.   

Abstract

In order to treat painful subluxation or dislocation secondary to cerebral palsy, 11 patients (12 hips) underwent combined femoral and Chiari pelvic osteotomies with additional soft-tissue releases at a mean age of 14.1 years (9.1 to 17.8). Relief of pain, improvement in movement of the hip, and in sitting posture, and ease of perineal care were recorded in all, and were maintained at a mean follow-up of 13.1 years (8 to 17.5). The improvement in general mobility was marginal, but those who were able to walk benefited the most. The radiological measurements made before operation were modified afterwards to use the lateral margin of the neoacetabulum produced by the pelvic osteotomy. The radiological migration index improved from a mean of 80.6% (61% to 100%) to 13.7% (0% to 33%) (p < 0.0001). The mean changes in centre edge angle and Sharp's angle were 72 degrees (56 degrees to 87 degrees; p < 0.0001) and 12.3 degrees (9 degrees to 15.6 degrees; p < 0.0001), respectively. Radiological evidence of progressive arthritic change was seen in one hip, in which only a partial reduction had been achieved, and there was early narrowing of the joint space in another. Painless heterotopic ossification was observed in one patient with athetoid quadriplegia. In seven hips the lateral Kawamura approach, elevating the greater trochanter, provided exposure for both osteotomies and allowed the construction of a dome-shaped iliac osteotomy, while protecting the sciatic nerve.

Entities:  

Mesh:

Year:  2006        PMID: 17012430     DOI: 10.1302/0301-620X.88B10.17742

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  8 in total

Review 1.  Cerebral palsy gait, clinical importance.

Authors:  Raluca Dana Tugui; Dinu Antonescu
Journal:  Maedica (Buchar)       Date:  2013-09

2.  Clinical and radiological outcome of combined femoral and Chiari osteotomies for subluxed or dislocated hips secondary to neuromuscular conditions: a minimum of 10-year follow-up.

Authors:  Michalis Zenios; Mark Hannan; Saqib Zafar; Andrew Henry; C S B Galasko; Tahir Khan
Journal:  Musculoskelet Surg       Date:  2012-05-06

3.  Long-term experience with Chiari's osteotomy.

Authors:  Rainer Kotz; Catharina Chiari; Jochen G Hofstaetter; Andreas Lunzer; Philipp Peloschek
Journal:  Clin Orthop Relat Res       Date:  2009-06-12       Impact factor: 4.176

4.  Migration percentage and odds of recurrence/subsequent surgery after treatment for hip subluxation in pediatric cerebral palsy: a meta-analysis and systematic review.

Authors:  K N Agarwal; C Chen; D M Scher; E R Dodwell
Journal:  J Child Orthop       Date:  2019-12-01       Impact factor: 1.548

5.  Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy.

Authors:  A Nazareth; S J Shymon; L Andras; R Y Goldstein; R M Kay
Journal:  J Child Orthop       Date:  2019-04-01       Impact factor: 1.548

6.  Mid-term clinical result of femoral varus osteotomy combined with Pemberton osteotomy in treating spastic hip subluxation.

Authors:  Jie Wen; Hong Liu; Sheng Xiao; Xin Li; Ke Fang; Zhongwen Tang; Shu Cao; Fanling Li
Journal:  J Pediatr Orthop B       Date:  2020-11       Impact factor: 1.473

7.  Tranexamic acid use decreases transfusion rate in children with cerebral palsy undergoing proximal femoral varus derotational osteotomy.

Authors:  Edward Compton; Rachel Y Goldstein; Alexander Nazareth; Stephen J Shymon; Lydia Andras; Robert M Kay
Journal:  Medicine (Baltimore)       Date:  2022-01-14       Impact factor: 1.817

8.  A balanced approach for stable hips in children with cerebral palsy: a combination of moderate VDRO and pelvic osteotomy.

Authors:  Kerstin Reidy; Christoph Heidt; Stefan Dierauer; Hanspeter Huber
Journal:  J Child Orthop       Date:  2016-06-27       Impact factor: 1.548

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.